The IBN SINA Pharmaceutical Industry PLC (IBNSINA)
A
| Pharmaceuticals & Chemicals
INTRADAY 1MIN CHART
Loading ...
Price: -
Volume: -
Today Analysis
The IBN SINA Pharmaceutical Industry PLC এর শেয়ারটি 310.00 BDT-এ লেনদেন হচ্ছে, যা বর্তমান ট্রেন্ডে পতনের দিকে। কোম্পানিটির NAV 125.69 BDT-এ অবস্থান করছে, যা দীর্ঘমেয়াদী বিনিয়োগের জন্য একটি নির্দেশক হিসেবে কাজ করে। কোম্পানির P/E Ratio নির্দেশ করে এটি তুলনামূলকভাবে আয়ের চেয়ে কতগুণ বেশি মূল্যে লেনদেন হচ্ছে। টেকনিক্যাল এনালাইসিস অনুযায়ী, সাপোর্ট লেভেল 300.70 BDT-এর কাছাকাছি হতে পারে, যেখানে শেয়ারটি ঘুরে দাঁড়াতে পারে। অন্যদিকে 320.85 BDT-এ একটি সম্ভাব্য রেজিস্ট্যান্স আছে, যেখানে দাম বাধা পেতে পারে। বিনিয়োগের সিদ্ধান্ত নেওয়ার আগে, মার্কেটের সামগ্রিক অবস্থা ও কোম্পানির ফান্ডামেন্টালগুলো বিবেচনা করা জরুরি।
(Disclaimer: This system generated summary is for informational purposes only and does not constitute financial advice.)
Market Depth (Live Order Book)
Buy Orders (Bids)
| Cum Qty | Volume | Price |
|---|---|---|
| No buy orders | ||
Sell Orders (Asks)
| Price | Volume | Cum Qty |
|---|---|---|
| No sell orders | ||
| Date | Close | Volume | Trade | Change | Ch(%) | Open | High | Low |
|---|---|---|---|---|---|---|---|---|
| Loading historical data... | ||||||||
01 Oct, 2026
IBNSINA: Board approves decision to purchase 24,321 sft Commercial Space
The company has informed that it has decided to purchase Commercial Space measuring area of 24,321 sft. located at Concord Lily Height's Plot: 08, Road: 16 (Old 27), Dhanmondi R/A, Dhaka 1209, Bangladesh at the cost of Tk. 57,43,01,158 (Taka Fifty Seven Crore Forty Three Lac One Thousand and One Hundred Fifty Eight) only (excluding registration fee and other relevant charges) and approved by the Board of Directors of the company in its 342nd meeting held on September 30, 2026.
01 Oct, 2026
IBNSINA: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (01.10.2026) following its corporate declaration.
01 Oct, 2026
IBNSINA: Dividend Declaration
The Board of Directors has recommended 77% Cash Dividend for the year ended June 30, 2026. Date of AGM: 23.11.2026, Time: 09:30 AM, Venue/Mode: Digital Platform. Record Date: 26.10.2026. The Company has also reported Consolidated EPS of Tk. 25.43, Consolidated NAV per share of Tk. 144.56 and Consolidated NOCFPS of Tk. 37.95 for the year ended June 30, 2026 as against Tk. 20.27, Tk. 125.69 and Tk. 23.16 respectively for the year ended June 30, 2025.
22 Sep, 2026
IBNSINA: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on September 30, 2026 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.
23 Apr, 2026
IBNSINA: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 4.67 for January-March 2026 as against Tk. 5.55 for January-March 2025; Consolidated EPS was Tk. 19.94 for July 2025-March 2026 as against Tk. 15.02 for July 2024-March 2025. Consolidated NOCFPS was Tk. 29.52 for July 2025-March 2026 as against Tk. 26.16 for July 2024-March 2025. Consolidated NAV per share was Tk. 139.10 as on March 31, 2026 and Tk. 125.69 as on June 30, 2025.
20 Apr, 2026
IBNSINA: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 22, 2026 at 2:45 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
27 Jan, 2026
IBNSINA: Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 8.20 for October-December 2025 as against Tk. 6.75 for October-December 2024; Consolidated EPS was Tk. 15.27 for July-December 2025 as against Tk. 9.47 for July-December 2024. Consolidated NOCFPS was Tk. 24.58 for July-December 2025 as against Tk. 17.25 for July-December 2024. Consolidated NAV per share was Tk. 134.41 as on December 31, 2025 and Tk. 125.69 as on June 30, 2025.
21 Jan, 2026
IBNSINA: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 26, 2026 at 2:45 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.
01 Jan, 2026
IBNSINA: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
04 Dec, 2025
IBNSINA: Credit Rating Result
Alpha Credit Rating PLC. has assigned Surveillance rating of the Company as "AA+" in the long term and "ST-1" in the short term along with Stable outlook based on audited financial statements up to 30 June, 2025 and relevant qualitative information till December 02, 2025.
12 Nov, 2025
IBNSINA: Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 7.08 for July-September 2025 as against Tk. 2.72 for July-September 2024. Consolidated NOCFPS was Tk. 5.46 for July-September 2025 as against Tk. 9.71 for July-September 2024. Consolidated NAV per share was Tk. 132.67 as on September 30, 2025 and Tk. 125.69 as on June 30, 2025.
05 Nov, 2025
IBNSINA: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2025 at 2:45 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
26 Oct, 2025
IBNSINA: Resumption after Record Date
Trading of the shares of the company will resume on 27.10.2025.
23 Oct, 2025
IBNSINA: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 26.10.2025.
21 Oct, 2025
IBNSINA: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 22.10.2025 to 23.10.2025 and trading of the shares will remain suspended on record date i.e., 26.10.2025.
05 Oct, 2025
IBNSINA: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (05.10.2025) following its corporate declaration.
05 Oct, 2025
IBNSINA: Dividend Declaration
The Board of Directors has recommended 64% Cash Dividend for the year ended June 30, 2025. Date of AGM: 23.11.2025, Time: 9:30 AM, Venue: Digital Platform. Record Date: 26.10.2025. The Company has also reported consolidated EPS of Tk. 20.27, consolidated NAV per share of Tk. 125.69 and consolidated NOCFPS of Tk. 23.16 for the year ended June 30, 2025 as against Tk. 21.46, Tk. 96.68 and Tk. 12.48 respectively for the year ended June 30, 2024.
23 Sep, 2025
IBNSINA: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on September 30, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
30 Jun, 2025
IBNSINA: Board of Directors approval for Land Purchase in Feni District
The company has informed that the Board of Directors in its meeting held on June 29, 2025 has approved the Land Purchase in Feni District. To view the details, please visit: https://www.dsebd.org/Annexure/2025/IBN-SINA-Pharmaceutical-Industry-PLC-PSI2025.pdf
29 Apr, 2025
IBNSINA: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 5.55 for January-March 2025 as against Tk. 4.31 for January-March 2024; Consolidated EPS was Tk. 15.02 for July 2024-March 2025 as against Tk. 16.32 for July 2023-March 2024. Consolidated NOCFPS was Tk. 26.16 for July 2024-March 2025 as against Tk. 15.50 for July 2023-March 2024. Consolidated NAV per share was Tk. 120.55 as on March 31, 2025 and Tk. 111.94 as on June 30, 2024.
22 Apr, 2025
IBNSINA: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
26 Jan, 2025
IBNSINA: Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 6.75 for October-December 2024 as against Tk. 6.70 for October-December 2023; Consolidated EPS was Tk. 9.47 for July-December 2024 as against Tk. 11.92 for July-December 2023. Consolidated NOCFPS was Tk. 17.25 for July-December 2024 as against Tk. 11.05 for July-December 2023. Consolidated NAV per share was Tk. 115.01 as on December 31, 2024 and Tk. 111.94 as on June 30, 2024.
21 Jan, 2025
IBNSINA: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 25, 2025 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
20 Jan, 2025
IBNSINA: Buy confirmation of Nominated Director
A. K. M. Sadrul Islam, Nominated Director of the Company, has further informed that he has completed his buying of 515 shares of the company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 09.01.2025.
09 Jan, 2025
IBNSINA: Buy Declaration of Nominated Director
A. K. M. Sadrul Islam, Nominated Director of the Company, has expressed his intention to buy 515 shares of the Company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. within next 30 working days.
05 Jan, 2025
IBNSINA: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
03 Dec, 2024
IBNSINA: Credit Rating Result
Alpha Credit Rating Limited (Alpha Rating) has assigned the Surveillance rating of the Company as "AA+" in the long term and "ST-1" in the short term along with Stable outlook based on the audited financial statements as on June 30, 2024 and relevant qualitative information till December 01, 2024.
13 Nov, 2024
IBNSINA: Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 2.72 for July-September 2024 as against Tk. 5.22 for July-September 2023; Consolidated NOCFPS was Tk. 9.71 for July-September 2024 as against Tk. 1.20 for July-September 2023. Consolidated NAV per share was Tk. 114.80 as on September 30, 2024 and Tk. 111.94 as on June 30, 2024.
10 Nov, 2024
IBNSINA: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
27 Oct, 2024
IBNSINA: Resumption after Record date
Trading of the shares of the company will resume on 28.10.2024.
24 Oct, 2024
IBNSINA: Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 27.10.2024.
22 Oct, 2024
IBNSINA: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 23.10.2024 to 24.10.2024 and trading of the shares of the company will remain suspended on record date i.e., 27.10.2024.
03 Oct, 2024
IBNSINA: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (03.10.2024) following its corporate declaration.
03 Oct, 2024
IBNSINA: Dividend Declaration
The Board of Directors has recommended 63% Cash Dividend for the year ended June 30, 2024. Date of AGM: 24.11.2024, Time: 9:30 AM, Venue: Digital Platform. Record Date: 27.10.2024. The Company has also reported Consolidated EPS of Tk. 21.46, Consolidated NAV per share of Tk. 111.94 and Consolidated NOCFPS of Tk. 12.48 for the year ended June 30, 2024 as against Tk. 19.38, Tk. 96.68 and Tk. 28.08 respectively for the year ended June 30, 2023.
24 Sep, 2024
IBNSINA: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 02, 2024 at 03:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
Total Records: 13 Years
| Year | Type | Cash(%) | Stock(%) | EPS | NAV | Remarks |
|---|---|---|---|---|---|---|
| 2025 | Final | 64.00% | - | 20.27 | 125.69 | 05-Oct-2025 |
| 2024 | Final | 63.00% | - | 21.46 | 111.94 | 03-Oct-2024 |
| 2023 | Final | 60.00% | - | 19.38 | 96.68 | 29-Aug-2023 |
| 2022 | Final | 60.00% | - | 19.39 | 83.36 | 06-Sep-2022 |
| 2021 | Final | 47.00% | - | 15.66 | 68.69 | 22-Sep-2021 |
| 2020 | Annual | 38.50% | - | 12.56 | 56.88 | 20-Sep-2020 |
| 2019 | Annual | 30.00% | - | 10.76 | 47.32 | 22-Sep-2019 |
| 2018 | Annual | 30.00% | 10.00% | 15.92 | 43.21 | 26-Sep-2018 |
| 2017 | Annual | 25.00% | 10.00% | 9.06 | 42.79 | 26-Sep-2017 |
| 2016 | Annual (18 Months) | 37.50% | 15.00% | 11.44 | 38.72 | 03-Oct-2016 |
| 2016 | Final (06 Months) | 12.50% | 5.00% | 3.51 | 38.72 | 03-Oct-2016 |
| 2016 | Interim (12 Months) | 25.00% | 10.00% | 7.93 | 37.10 | 04-Apr-2016 |
| 2014 | Annual | 30.00% | 5.00% | 5.95 | 31.77 | 20-Apr-2015 |
30-Day Block Transactions
| Date | Max Price | Min Price | Trades | Quantity | Value (Mn) |
|---|---|---|---|---|---|
| 2026-09-27 | 291.00 | 291.00 | 1 | 7,734 | 2.251 |
Company Info
Trading Code
IBNSINA
Category : Sector
A : Pharmaceuticals & Chemicals
NAV
125.69 Tk.
P/E Audited
15.70
Paid up Capital
312.44 crore
Authorized Capital
500.00 crore
Market Capital
9,841.74 crore
Total Securities
31,243,627
Reserve & Surplus
3,625.62 crore
Website
http://www.ibnsinapharma.com
Current Shareholding
Public Holding: 0.94 Cr unit
Public: 29.95% (0.94 Cr unit)
Director: 44.68% (1.40 Cr unit)
Institute: 25.37% (0.79 Cr unit)
Foreign: 0.00% (0.00 Cr unit)
Govt: 0.00% (0.00 Cr unit)
EPS History
NAV History
Dividend History
Cash Dividend
Stock Dividend
Historical Monthly Performance
Compare cumulative monthly performance.
Best Month
-
Worst Month
-
Avg MoM
-
Positive
-
Positive Yrs
-
Historical Insight
-
Historical Seasonality
Holding Period Returns
Entry → Exit Analysis
Entry Month:
Select an entry month to view historical holding period outcomes.
* Historical performance is not indicative of future results. Historical calculations are based on past closing prices and do not constitute investment advice. Dividends are not included.
| Period Ending: |
2021
07/10/2026
|
2022
07/10/2026
|
2023
07/10/2026
|
2024
07/10/2026
|
2025
07/10/2026
|
|---|---|---|---|---|---|
| Total Revenues | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Gross Profit | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Expenses | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Pre-tax Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EBITDA | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EPS (Basic) | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash & Equivalents | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Debt | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Equity | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Operations | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Investing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Financing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Capital Expenditure | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Free Cash Flow | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Change in Cash | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
Unlock Full Financial Data
Upgrade to PRO to access complete historical financial statements, quarterly reports, and deep fundamental analysis.
Upgrade to PROThe IBN SINA Pharmaceutical Industry PLC
A | Pharmaceuticals & Chemicals
Today-
15 dys-
30 dys-
3 mths-
6 mths-
1 yr-
LTP:-
Open:-
High:-
Low:-
YCP:-
Vol:-
52W H:-
52W L:-
Crct Lw:-
Circuit Up:-
Value:-
M. Cap:-
P/E (Un/A):-
EPS:-
NAV:-
Paid-up:-
Ttl Share:-
Yr end:-
Reserve:-
ROE:-
EPS Q2-
EPS Q3-
EPS ANN-
EPS Q1-
DIV-
DIV YIELD-
Last AGM: -
Record Date: -
Shareholding
(as on -)
Public
0%
Director
0%
Institute
0%
Foreign
0%
Govt.
0%
Market Overview
Loading Data...
(%)
Day Open
Total Trade
Day High
Total Volume
Day Low
Value (Cr)
MARKET STATUS
Up
Down
Unchanged
All Instruments
| Symbol | LTP | Chg% |
|---|---|---|
| Loading... | ||
Sectors
| Sector | Chg% |
|---|---|
| Loading... | |
Stock Screener
Quick Screens
| Symbol | LTP | PE |
|---|---|---|
| Run filter to see results | ||
Alerts
Favorites
Watchlists
Portfolio
My Screeners
| Symbol | LTP | PE |
|---|
Run filter to see results
Market Movers
| # | Symbol | LTP | Chg% |
|---|---|---|---|
| Loading... | |||
AI Insights
Business Pro user exclusive
Login to see